Fusion Pharmaceuticals Research Centres
Provides accessible, scientific, and confidential interactive therapy program for depression online.
.jpg)
%20.jpg)
Last Funding Type:
Venture - Series Unknown
Funding Status:
IPO
Headquarters:
Canada
Founded Date:
01.01.2014
Investor Type:
For Profit
Total Funding:
$170.9M
Technology:
Genetic Test & Molecular Diagnostics
Employee Number:
11-50
Estimated Revenue:
$1M to $10M
Investors Number:
16
Industry:
Deep Diagnostics